1. Home
  2. MURA vs QRHC Comparison

MURA vs QRHC Comparison

Compare MURA & QRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MURA
  • QRHC
  • Stock Information
  • Founded
  • MURA 2013
  • QRHC N/A
  • Country
  • MURA Ireland
  • QRHC United States
  • Employees
  • MURA N/A
  • QRHC N/A
  • Industry
  • MURA
  • QRHC Environmental Services
  • Sector
  • MURA
  • QRHC Utilities
  • Exchange
  • MURA Nasdaq
  • QRHC Nasdaq
  • Market Cap
  • MURA 36.0M
  • QRHC 32.3M
  • IPO Year
  • MURA N/A
  • QRHC N/A
  • Fundamental
  • Price
  • MURA $2.09
  • QRHC $1.48
  • Analyst Decision
  • MURA Buy
  • QRHC
  • Analyst Count
  • MURA 2
  • QRHC 0
  • Target Price
  • MURA $6.00
  • QRHC N/A
  • AVG Volume (30 Days)
  • MURA 103.1K
  • QRHC 1.1M
  • Earning Date
  • MURA 11-04-2025
  • QRHC 11-10-2025
  • Dividend Yield
  • MURA N/A
  • QRHC N/A
  • EPS Growth
  • MURA N/A
  • QRHC N/A
  • EPS
  • MURA N/A
  • QRHC N/A
  • Revenue
  • MURA N/A
  • QRHC $270,706,000.00
  • Revenue This Year
  • MURA N/A
  • QRHC N/A
  • Revenue Next Year
  • MURA N/A
  • QRHC $4.24
  • P/E Ratio
  • MURA N/A
  • QRHC N/A
  • Revenue Growth
  • MURA N/A
  • QRHC N/A
  • 52 Week Low
  • MURA $0.95
  • QRHC $1.11
  • 52 Week High
  • MURA $4.74
  • QRHC $8.37
  • Technical
  • Relative Strength Index (RSI)
  • MURA 52.55
  • QRHC 49.82
  • Support Level
  • MURA $2.06
  • QRHC $1.41
  • Resistance Level
  • MURA $2.10
  • QRHC $1.64
  • Average True Range (ATR)
  • MURA 0.01
  • QRHC 0.16
  • MACD
  • MURA 0.00
  • QRHC 0.03
  • Stochastic Oscillator
  • MURA 66.67
  • QRHC 61.40

About MURA Mural Oncology plc

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.

About QRHC Quest Resource Holding Corporation

Quest Resource Holding Corp is a national provider of waste and recycling services to customers from across multiple industry sectors that are typically larger, multi-location businesses. The company creates customer-specific programs and perform the related services for the collection, processing, recycling, disposal, and tracking of waste streams and recyclables. The company's services focus on the waste streams and recyclables from box, grocers, and other specialty retailers; automotive after-market operations such as automotive maintenance, quick lube, dealerships, and collision repair; transportation, logistics, and fleet operators; manufacturing and industrial facilities; multi-family and commercial properties; restaurant chains and food operations, etc.

Share on Social Networks: